Learn more at LeadIQ.com

Insights

Gathering insights about Relypsa…

Similar companies to Relypsa

Relypsa Tech Stack

Relypsa uses 8 technology products and services including SAS, Cloudflare, Responsa, and more. Explore Relypsa's tech stack below.

SAS
Business Intelligence
Cloudflare
Content Management System
Responsa
Customer Service
Exhibit
Javascript Graphics
Informa
Miscellaneous
Microsoft Windows Server
Operating Systems
Python
Programming Languages
Concur
Travel And Expense Management

Media & News

Vifor Pharma has issues with potentially breaching antitrust laws.
In an unprecedented move, the UK's Competition and Markets Authority (CMA) has opened an investigation into Vifor Pharma, a leading pharmaceutical company, for potentially breaching antitrust laws.
Jan 31, 2024 | medriva.com
Vifor Pharma had issues with alleged anti-competitive disparagement of iron deficiency medicine made on Apr 19th '24.
Vifor Pharma under investigation for alleged disparagement of rival's iron-deficiency treatment.
Jan 31, 2024 | medriva.com
Winhealth Pharma partnered with Vifor Pharma on Jan 16th '23.
Winhealth Pharma today announced that the company has signed a long-term exclusive licensing agreement with Vifor Fresenius Medical Care Renal Pharma (VFMCRP) for the co-development and commercialization of KORSUVA® (difelikefalin) Injection (“i.v. Korsuva”) for the treatment of moderate-to-severe pruritus in adult patients undergoing hemodialysis in China.
Jan 15, 2023 | www.cmocro.com
Winhealth partnered with Vifor Pharma on Jan 16th '23.
Winhealth Pharma today announced that the company has signed a long-term exclusive licensing agreement with Vifor Fresenius Medical Care Renal Pharma (VFMCRP) for the co-development and commercialization of KORSUVA® (difelikefalin) Injection (“i.v. Korsuva”) for the treatment of moderate-to-severe pruritus in adult patients undergoing hemodialysis in China.
Jan 15, 2023 | www.winhealth.hk
Vifor Pharma acquired OM Pharma Ltd on Jan 1st '09.
In 2009, OM Pharma was then acquired by the Vifor Pharma group.
Jun 14, 2022 | www.cordenpharma.com
Vifor Pharma is developing KAPRUVIA.
Brand Institute is proud to announce having worked with Vifor Pharma in developing the brand name KAPRUVIA® (difelikefalin), an injection used to treat moderate to severe pruritus (itching) associated with chronic kidney disease in adult patients on hemodialysis.
Jun 13, 2022 | www.prnewswire.co.uk
Brand Institute Inc. partners with Vifor Pharma.
Brand Institute is proud to announce having worked with Vifor Pharma in developing the brand name KAPRUVIA® (difelikefalin), an injection used to treat moderate to severe pruritus (itching) associated with chronic kidney disease in adult patients on hemodialysis.
Jun 13, 2022 | www.prnewswire.co.uk

Relypsa's Email Address Formats

Relypsa uses at least 2 format(s):

Relypsa Email Formats	Example	Percentage
FLast@relypsa.com	JDoe@relypsa.com	88%
Last@relypsa.com	Doe@relypsa.com	6%
FiLast@relypsa.com	JoDoe@relypsa.com	2%
First.Last@relypsa.com	John.Doe@relypsa.com	1%
LF@relypsa.com	DJ@relypsa.com	1%
First@relypsa.com	John@relypsa.com	1%
LFirst@relypsa.com	DJohn@relypsa.com	1%
First.Last@viforpharma.com	John.Doe@viforpharma.com	91%
FLast@viforpharma.com	JDoe@viforpharma.com	4%
Last.First@viforpharma.com	Doe.John@viforpharma.com	3%
First.Middle@viforpharma.com	John.Michael@viforpharma.com	2%

Frequently Asked Questions

Where is Relypsa's headquarters located?

Relypsa's main headquarters is located at 100 Cardinal Way Redwood City, CA 94063 US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Relypsa's phone number?

You can contact Relypsa's main corporate office by phone at

+1-650-421-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Relypsa's stock symbol?

Relypsa is a publicly traded company; the company's stock symbol is RLYP.

What is Relypsa's official website and social media links?

Relypsa's official website is viforpharma.com and has social profiles on LinkedIn.

What is Relypsa's SIC code NAICS code?

Relypsa's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Relypsa have currently?

As of August 2023, Relypsa has approximately 201 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Vice President, CMC Development & Manufacturing Strategy: A. K.Director, Strategic Insights & Analytics: N. C.Medical Science Director: A. K.. Explore Relypsa's employee directory with LeadIQ.

What industry does Relypsa belong to?

Relypsa operates in the Biotechnology Research industry.

What technology does Relypsa use?

Relypsa's tech stack includes SASCloudflareResponsaExhibitInformaMicrosoft Windows ServerPythonConcur.

What is Relypsa's email format?

Relypsa's email format typically follows the pattern of . Find more Relypsa email formats with LeadIQ.

How much funding has Relypsa raised to date?

As of August 2023, Relypsa has raised $150M in funding. The last funding round occurred on May 03, 2016 for $150M.

When was Relypsa founded?

Relypsa was founded in 2007.

Relypsa

Relypsa

Biotechnology ResearchCalifornia, United States201-500 Employees

Relypsa is now Vifor Pharma! The final stage of our integration is complete with the renaming of Relypsa to Vifor Pharma, marking a significant milestone in our journey to being the global leader in iron deficiency, nephrology and cardio-renal therapies. 

Our US office is located in Redwood City, California, where with the expertise from our teams, we continue to strive to help patients around the world with severe and chronic diseases, lead better, healthier lives.  We are proud to have developed Veltassa® (patiromer) for oral suspension, based on our rich legacy in polymer science. 

Follow https://www.linkedin.com/company/viforpharma to stay up to date on the latest news and milestones. 

(Our community guidelines: viforpharma.com/linkedin-cg)

Company Overview

Headquarters: 100 Cardinal Way Redwood City, CA 94063 US
Phone number: ✕
Access Insights for Relypsa and Millions of Other Companies
Sign up for full access to Relypsa information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-650-421-****
Website: viforpharma.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: RLYP
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2007
Employees: 201-500

Media & News

Funding & Financials

$150M
Relypsa has raised a total of $150M of funding over 10 rounds. Their latest funding round was raised on May 03, 2016 in the amount of $150M.

Funding & Financials

$150M
Relypsa has raised a total of $150M of funding over 10 rounds. Their latest funding round was raised on May 03, 2016 in the amount of $150M.

Company Leadership

A. K.
Vice President, CMC Development & Manufacturing Strategy
✕
Access Insights for Relypsa and Millions of Other Companies
Sign up for full access to Relypsa information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Relypsa and Millions of Other Companies
Sign up for full access to Relypsa information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
N. C.
Director, Strategic Insights & Analytics
✕
Access Insights for Relypsa and Millions of Other Companies
Sign up for full access to Relypsa information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Relypsa and Millions of Other Companies
Sign up for full access to Relypsa information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. K.
Medical Science Director
✕
Access Insights for Relypsa and Millions of Other Companies
Sign up for full access to Relypsa information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Relypsa and Millions of Other Companies
Sign up for full access to Relypsa information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
C. H.
Director
✕
Access Insights for Relypsa and Millions of Other Companies
Sign up for full access to Relypsa information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Relypsa and Millions of Other Companies
Sign up for full access to Relypsa information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
C. C.
Senior Medical Director, Drug Safety And Pharmacovigilance
✕
Access Insights for Relypsa and Millions of Other Companies
Sign up for full access to Relypsa information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Relypsa and Millions of Other Companies
Sign up for full access to Relypsa information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

C. G.
Executive Medical Director
✕
Access Insights for Relypsa and Millions of Other Companies
Sign up for full access to Relypsa information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Relypsa and Millions of Other Companies
Sign up for full access to Relypsa information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
H. W.
Associate Director, Data Systems
✕
Access Insights for Relypsa and Millions of Other Companies
Sign up for full access to Relypsa information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Relypsa and Millions of Other Companies
Sign up for full access to Relypsa information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. M.
Director - Executive Director Analytical Development & Qc
✕
Access Insights for Relypsa and Millions of Other Companies
Sign up for full access to Relypsa information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Relypsa and Millions of Other Companies
Sign up for full access to Relypsa information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
L. R.
Senior Director, Finance Operations And Controller
✕
Access Insights for Relypsa and Millions of Other Companies
Sign up for full access to Relypsa information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Relypsa and Millions of Other Companies
Sign up for full access to Relypsa information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
N. K.
Director Of Pharmaceutical Development And Manufacturing
✕
Access Insights for Relypsa and Millions of Other Companies
Sign up for full access to Relypsa information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Relypsa and Millions of Other Companies
Sign up for full access to Relypsa information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.